Uptravi for Pulmonary Arterial Hypertension User Reviews (Page 2)
Uptravi has an average rating of 5.5 out of 10 from a total of 22 reviews for the treatment of Pulmonary Arterial Hypertension. 27% of reviewers reported a positive experience, while 27% reported a negative experience.
Reviews for Uptravi
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Pulmonary Arterial Hypertension
Care guides
Medicine.com guides (external)
More about Uptravi (selexipag)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: agents for pulmonary hypertension
- En español
Patient resources
- Uptravi drug information
- Uptravi (Selexipag Intravenous) (Advanced Reading)
- Uptravi (Selexipag Oral) (Advanced Reading)
"I am now at 1000 a day and night, 800 was hard. I was having really bad back pain on my left side, once that subsided, I slowly went up. So far, I've noticed my breathing is better."